obesity drug news today glp-1 today The popularity of drugs has exploded. Once a relatively obscure class of drugs prescribed for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects GLP-1 Obesity Drug News Today:
Description
The semaglutide group showed a significantly improved Kansas City Cardiomyopathy Questionnaire clinical summary score and a longer 6-min walking distance from baseline (21.5 m and 1.2 m in the semaglutide and placebo groups, respectively, intergroup difference 20.3 m, 95% CI 8.632.1 m), compared with that in the placebo group despite the relatively short observation period of 52 weeks
Needle-Free Convenience: The most obvious benefit is the elimination of injections
doi: 10.1016/0014-5793(81)80772-7 [DOI] [PubMed] [Google Scholar] 87
Role of gastrointestinal hormones in postprandial reduction of bone resorption
This is a sensible progression, and it is increasingly common in clinical practice
